Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)-Reference-Cited by-同舟云学术

Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)

Published:2020-12 Issue: Volume:141 Page:21-29
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Tao Yungan,Aupérin Anne,Sun Xushan,Sire Christian,Martin Laurent,Coutte Alexandre,Lafond Cedrik,Miroir Jessica,Liem Xavier,Rolland Frederic,Even Caroline,Nguyen France,Saada Esma,Maillard Aline,Colin-Batailhou Natacha,Thariat Juliette,Guigay Joël,Bourhis Jean

Funder

GORTEC

Alliance Merck-Pfizer which

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference13 articles.

1. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer;Pignon;Lancet,2000

2. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

3. Improved outcome by adding concurrent chemotherapy to cetuximab and radiotherapy for locally advanced head and neck carcinomas: results of the GORTEC 2007-01 phase III randomized trial;Tao;J Clin Oncol,2018

4. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck;Ferris;N Engl J Med,2016

5. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Motzer;N Engl J Med,2019

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the efficacy and safety of different neoadjuvant immunotherapy combinations in locally advanced HNSCC: a systematic review and meta-analysis;Frontiers in Immunology;2024-08-29

2. Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma;Frontiers in Immunology;2024-08-21

3. MHC-I and PD-L1 Expression is Associated with Decreased Tumor Outgrowth and is Radiotherapy-inducible in the Murine Head and Neck Squamous Cell Carcinoma Model MOC1;Molecular Imaging and Biology;2024-07-15

4. Anti‑epidermal growth factor receptor monoclonal antibody therapy in locally advanced head and neck cancer: A systematic review of phase III clinical trials;Medicine International;2024-05-29

5. Response to Yilmaz et al.;Anti-Cancer Drugs;2024-04-03